The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for A Milelli


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate.EBI
Alma Mater Studiorum-University of Bologna
Oxidative stress in Alzheimer's disease: are we connecting the dots?EBI
University of Bologna
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties.EBI
University of Bologna
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.EBI
University of Bologna
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.EBI
University of Bologna
Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.EBI
Department of Pharmaceutical Sciences-Alma Mater Studiorum-Bologna University
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer.EBI
University of Bologna
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery?EBI
University of Turin
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer.EBI
Alma Mater Studiorum-Universit£
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.EBI
Alma Mater Studiorum-University of Bologna
Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains.EBI
Alma Mater Studiorum-University of Bologna
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.EBI
University of Padova
In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers.EBI
Chiba University
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors.EBI
Alma Mater Studiorum-University of Bologna
Novel Polyamine-Naphthalene Diimide Conjugates Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming.EBI
Alma Mater Studiorum-University of Bologna
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.EBI
Alma Mater Studiorum-University of Bologna